HU9603158D0 - Pharmaceutical composition for treating glaucoma containing terazosin - Google Patents

Pharmaceutical composition for treating glaucoma containing terazosin

Info

Publication number
HU9603158D0
HU9603158D0 HU9603158A HU9603158A HU9603158D0 HU 9603158 D0 HU9603158 D0 HU 9603158D0 HU 9603158 A HU9603158 A HU 9603158A HU 9603158 A HU9603158 A HU 9603158A HU 9603158 D0 HU9603158 D0 HU 9603158D0
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
treating glaucoma
glaucoma containing
terazosin
containing terazosin
Prior art date
Application number
HU9603158A
Other languages
Hungarian (hu)
Other versions
HUT76468A (en
Inventor
Takaaki Deguchi
Katsuhiro Inada
Takahiro Ogawa
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of HU9603158D0 publication Critical patent/HU9603158D0/en
Publication of HUT76468A publication Critical patent/HUT76468A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU9603158A 1994-05-18 1995-05-15 Pharmaceutical composition for treating glaucoma containing terazosin HUT76468A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10367694 1994-05-18

Publications (2)

Publication Number Publication Date
HU9603158D0 true HU9603158D0 (en) 1997-01-28
HUT76468A HUT76468A (en) 1997-09-29

Family

ID=14360400

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603158A HUT76468A (en) 1994-05-18 1995-05-15 Pharmaceutical composition for treating glaucoma containing terazosin

Country Status (10)

Country Link
EP (1) EP0759756A1 (en)
JP (1) JPH10500130A (en)
CN (1) CN1148810A (en)
AU (1) AU2420195A (en)
BR (1) BR9507732A (en)
CA (1) CA2187361A1 (en)
HU (1) HUT76468A (en)
PL (1) PL317190A1 (en)
TW (1) TW304879B (en)
WO (1) WO1995031200A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454544A1 (en) * 2001-07-02 2003-01-16 Santen Pharmaceutical Co., Ltd. Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient
WO2003006061A1 (en) * 2001-07-13 2003-01-23 Kissei Pharmaceutical Co., Ltd. Medicinal compositions for opthalmic use
CN104840436B (en) * 2015-06-11 2017-12-05 刘磊 Pharmaceutical composition
WO2017002846A1 (en) * 2015-06-30 2017-01-05 株式会社ニデック Visual function measurement device and visual function measurement program
CN114767688A (en) * 2019-09-04 2022-07-22 武汉科福新药有限责任公司 Transdermal penetration-promoting composition and application thereof in timolol preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824863B2 (en) * 1989-07-12 1998-11-18 エーザイ株式会社 α ▲ Lower 1 ▼ -Blocker eye drops
DE436726T1 (en) * 1989-08-03 1992-02-06 Eisai Co., Ltd., Tokio/Tokyo METHOD FOR PHOTOSTABILIZING EYE RINSE SOLUTIONS AND PHOTOSTABILIZED EYE RINSE SOLUTION.
US5256667A (en) * 1991-09-25 1993-10-26 Merck & Co., Inc. Quinazolinones and pyridopyrimidinones

Also Published As

Publication number Publication date
PL317190A1 (en) 1997-03-17
CN1148810A (en) 1997-04-30
TW304879B (en) 1997-05-11
HUT76468A (en) 1997-09-29
WO1995031200A1 (en) 1995-11-23
BR9507732A (en) 1997-08-19
CA2187361A1 (en) 1995-11-23
EP0759756A1 (en) 1997-03-05
AU2420195A (en) 1995-12-05
JPH10500130A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
HUP9602056A2 (en) Novel pharmaceutical composition containing phenofibrate
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
GB9208339D0 (en) Treatment composition
GB2264235B (en) Composition for nasal treatment
GB2302018B (en) Ophthalmic pharmaceutical composition
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
EP0803255A4 (en) Medicinal composition
GB9519667D0 (en) Pharmaceutical composition
IL115843A0 (en) Pharmaceutical composition containing cisapride-(l)-tartrate
IL112024A0 (en) Pharmaceutical compositions for treating gastointestinal motility disorders
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
GB9525194D0 (en) Pharmaceutical composition
GB9502695D0 (en) Pharmaceutical composition
HU9603158D0 (en) Pharmaceutical composition for treating glaucoma containing terazosin
HUT74745A (en) Pharmaceutical compositions containing p antagonist for treating pruritis, eye- and eyelid-acs and eye-and eyelid dysaesthesia
IL109758A0 (en) Pharmaceutical compositions for treating ulcer
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
PL311159A1 (en) Pharmaceutical composition for treating psoriasis
ZA957043B (en) Novel pharmaceutical composition
HUP9602732A3 (en) Pharmaceutical composition comprising lanperisone
HUT71416A (en) (piperidino-alkyl)-aryl-ethers, pharmaceutical compositions containing them and process for producing thereof
ZA941531B (en) Improved pharmaceutical composition
GB9414182D0 (en) Pharmaceutical composition
ZA953965B (en) Pharmaceutical composition
HU9400523D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee